Loading
Total declarations
Companies
▲ Purchases (23 ops.)
▼ Sales (9 ops.)
Latest filing published 22 Sept 2015 for ImmunoCellular Therapeutics, Ltd..
Insider track record
Disclosed buys
23
Disclosed sells
9
Signal history
No signal scores available.
Closed purchases
Market purchases
23
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Gary Titus: trading record in brief
Gary Titus has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Sciclone Pharmaceuticals Inc, Oruka Therapeutics, Inc. and Kosan Biosciences Inc. Over a trading history stretching from 31 August 2005 to 18 September 2015, the count stands at 48 filings.
On the open market, the record shows 23 purchases worth €92k and 9 sales worth €1.6M. Netting one side against the other leaves €1.6M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant and 10 option exercises.
Half of the purchases are above €2,031 and half below.
The record was last updated on 22 September 2015 with a share grant in ImmunoCellular Therapeutics, Ltd. The last purchase on record was published on 20 December 2013, which is 4,691 days ago. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Gary Titus
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations47 total
10,000 shares0Common StockSEC:0000899243-15-005203:0
100 shares@ US$0.7799Common StockSEC:0001181431-13-064026:0
Canonical exit: 20 Mar 2014 (T+90)
17,900 shares@ US$0.78Common StockSEC:0001181431-13-064026:1
Canonical exit: 20 Mar 2014 (T+90)
261 shares@ US$3.842Common StockSEC:0001298900-12-000006:0
Canonical exit: 29 Aug 2012 (T+90)
15,029 shares@ US$0.95Common StockSEC:0001298900-12-000006:1
15,029 shares@ US$7.05Common StockSEC:0001298900-12-000006:2
36,954 shares@ US$0.95Common StockSEC:0001298900-12-000006:3
36,954 shares@ US$6.99Common StockSEC:0001298900-12-000006:4
29,624 shares@ US$0.95Common StockSEC:0001298900-12-000006:5
29,624 shares@ US$6.99Common StockSEC:0001298900-12-000006:6
9,357 sharesCommon StockSEC:0001298900-12-000004:0
229 shares@ US$3.98Common StockSEC:0001298900-12-000002:0
Canonical exit: 29 Nov 2011 (T+90)
241 shares@ US$3.78Common StockSEC:0001298900-12-000002:1
Canonical exit: 28 Feb 2012 (T+90)
241 shares@ US$3.78Common StockSEC:0001298900-12-000002:2
Canonical exit: 29 May 2012 (T+90)
1,075 shares@ US$4.65Common StockSEC:0001298900-11-000002:0
Canonical exit: 16 Nov 2011 (T+90)
258 shares@ US$3.60Common StockSEC:0000880771-11-000023:0
Canonical exit: 29 Aug 2011 (T+90)
2,000 shares@ US$4.96Common StockSEC:0000880771-11-000023:1
Canonical exit: 13 Sept 2011 (T+90)
197 shares@ US$4.93Common StockSEC:0000880771-11-000023:2
Canonical exit: 13 Sept 2011 (T+90)
431 shares@ US$2.05Common StockSEC:0000880771-11-000002:0
Canonical exit: 29 Nov 2010 (T+90)
269 shares@ US$2.15Common StockSEC:0000880771-11-000002:1
Canonical exit: 28 Feb 2011 (T+90)
411 shares@ US$3.29Common StockSEC:0000880771-11-000002:2
Canonical exit: 29 May 2011 (T+90)
2,500 shares@ US$3.39Common StockSEC:0001298900-10-000004:0
Canonical exit: 9 Aug 2010 (T+90)
1,625 shares@ US$1.75Common StockSEC:0000880771-09-000011:0
Canonical exit: 20 Aug 2009 (T+90)
3,000 shares@ US$1.73Common StockSEC:0000880771-09-000011:1
Canonical exit: 20 Aug 2009 (T+90)
5,000 shares@ US$1.00Common StockSEC:0001451798-08-000002:0
Canonical exit: 11 Mar 2009 (T+90)
25 of 47 declarations
